Clinical trial
Pharmacokinetic Evaluation of Testosterone Gel (1%)
NCT00193700 · Solvay Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00193700 |
|---|---|
| Title | Pharmacokinetic Evaluation of Testosterone Gel (1%) |
| Official title | Pharmacokinetic Evaluation of Testosterone Gel (1%) in Prepubertal Boys of Adolescent Age |
| Lead sponsor | Solvay Pharmaceuticals, Industry |
| Collaborators | Unimed Pharmaceuticals Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Primary or Secondary Hypogonadism, Constitutional Delay in Growth and Puberty (CDGP) |
| Intervention type | Drug |
| Interventions | Testosterone Gel (1%) |
| Start date | Aug 1, 2002 |
| First posted | Sep 19, 2005 |
| Last update posted | Dec 25, 2006 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: